Neuropsychopharmacology
The effect of lysergic acid diethylamide (LSD) on whole-brain functional and effective connectivity
2023-04-25
Neuropsychopharmacology, Published online: 25 April 2023; doi:10.1038/s41386-023-01574-8
The effect of lysergic acid diethylamide (LSD) on whole-brain functional and effective connectivityFonte: Neuropsychopharmacology, Peter Bedford
AI-based analysis of social media language predicts addiction treatment dropout at 90 days
2023-04-24
Neuropsychopharmacology, Published online: 24 April 2023; doi:10.1038/s41386-023-01585-5
AI-based analysis of social media language predicts addiction treatment dropout at 90 daysFonte: Neuropsychopharmacology, Brenda Curtis
Neural complexity EEG biomarkers of rapid and post-rapid ketamine effects in late-life treatment-resistant depression: a randomized control trial
2023-04-19
Neuropsychopharmacology, Published online: 19 April 2023; doi:10.1038/s41386-023-01586-4
Neural complexity EEG biomarkers of rapid and post-rapid ketamine effects in late-life treatment-resistant depression: a randomized control trialFonte: Neuropsychopharmacology, Nicholas Murphy
Transdiagnostic evaluation of epigenetic age acceleration and burden of psychiatric disorders
2023-04-17
Neuropsychopharmacology, Published online: 17 April 2023; doi:10.1038/s41386-023-01579-3
Transdiagnostic evaluation of epigenetic age acceleration and burden of psychiatric disordersFonte: Neuropsychopharmacology, Natan Yusupov
LPA1 receptors in the lateral habenula regulate negative affective states associated with alcohol withdrawal
2023-04-14
Neuropsychopharmacology, Published online: 14 April 2023; doi:10.1038/s41386-023-01582-8
LPA1 receptors in the lateral habenula regulate negative affective states associated with alcohol withdrawalFonte: Neuropsychopharmacology, Zhiheng Ren
Robust aversive effects of trace amine-associated receptor 1 activation in mice
2023-04-13
Neuropsychopharmacology, Published online: 13 April 2023; doi:10.1038/s41386-023-01578-4
Robust aversive effects of trace amine-associated receptor 1 activation in miceFonte: Neuropsychopharmacology, Shkelzen Shabani
Predictors of placebo response in three large clinical trials of the V1a receptor antagonist balovaptan in autism spectrum disorder
2023-04-12
Neuropsychopharmacology, Published online: 12 April 2023; doi:10.1038/s41386-023-01573-9
Predictors of placebo response in three large clinical trials of the V1a receptor antagonist balovaptan in autism spectrum disorderFonte: Neuropsychopharmacology, Russell Tobe
Pharmacogenetic activation of parvalbumin interneurons in the prefrontal cortex rescues cognitive deficits induced by adolescent MK801 administration
2023-04-11
Neuropsychopharmacology, Published online: 11 April 2023; doi:10.1038/s41386-023-01576-6
Pharmacogenetic activation of parvalbumin interneurons in the prefrontal cortex rescues cognitive deficits induced by adolescent MK801 administrationFonte: Neuropsychopharmacology, Linda A. Chamberlin